Related Experiment Video
Updated: Jul 10, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
[Corticosteroid therapy of asthma].
P Chanez1, I Vachier, F B Michel
1Clinique des Maladies respiratoires, CHU de Montpellier. chanez@montp.inserm.fr
Presse Medicale (Paris, France : 1983)
|October 20, 2000
Summary
Glucocorticoids are essential for treating asthma by reducing bronchial inflammation. However, understanding individual patient sensitivity to these steroids remains a challenge for effective treatment.
Area of Science:
- Pulmonology
- Pharmacology
- Immunology
Background:
- Bronchial inflammation is a key factor in asthma, leading to bronchoconstriction and hyperreactivity.
- Glucocorticoids are the primary treatment for asthma, targeting multiple inflammatory pathways.
- Inhaled corticosteroids are widely recommended for early asthma management.
Purpose of the Study:
- To explore the mechanisms of glucocorticoid action in bronchial inflammation.
- To address the challenges in evaluating individual patient sensitivity to glucocorticoids.
- To understand the variability in glucocorticoid response among asthma patients.
Main Methods:
- Review of molecular and cellular mechanisms of glucocorticoid action.
- Analysis of glucocorticoid interaction with inflammatory and structural cells.
- Examination of gene transcription modulation via cytoplasmic receptors.
Main Results:
- Glucocorticoids affect all inflammatory and structural cells in the airways.
- The mechanism involves binding to cytoplasmic receptors and influencing DNA transcription.
- While most patients respond, a small subset shows insensitivity, necessitating further investigation.
- Individual variability in glucocorticoid sensitivity exists but is not fully understood in asthmatics.
Conclusions:
- Glucocorticoids are crucial for managing asthma by targeting bronchial inflammation.
- Individual sensitivity to glucocorticoids varies, and identifying non-responders requires further research.
- Defining and adapting criteria for glucocorticoid responders and non-responders is essential for personalized asthma care.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: